Biotechs Hope to Develop Next-Gen CRISPR Gene Editing in 2022
"The era of CRISPR is just beginning," said Benjamin Oakes, the CEO of the gene-editing startup Scribe Therapeutics.
Source: businessinsider.com
Page 21 - Code Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Code Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Code Therapeutics Today - Breaking & Trending Today
TransCode Therapeutics To Participate at MedInvest Oncology Investor Conference
07.12.2021 - BOSTON, Dec. 06, 2021 (GLOBE NEWSWIRE) - TransCode Therapeutics, Inc. (Nasdaq: RNAZ) today announced that it will be attending and presenting at the MedInvest Oncology Investor Conference. TransCode’s Chief Executive Officer, Michael Dudley, will ...
Source: wallstreet-online.de
Marketing Agency Swaps North Dallas Space for Downtown's One Main Place
Plus Smoothie King CEO launches new Asian concept; Rosewood Property Company and Champion Partners started construction on South Dallas industrial; and more.
Source: dmagazine.com
ReCode Therapeutics gets $80M to deliver on new RNA therapies for the lungs
ReCode Therapeutics closed an $80 million Series B round of financing that included Pfizer and Sanofi as investors. The startup’s technology uses lipid nanoparticles to deliver genetic medicines, and its two lead programs are for rare lung disorders.
Source: medcitynews.com
ReCode Therapeutics Presents Preclinical Data Using SORT-LNP™ and RNA Platforms to Rescue CFTR Function at the 44th European Cystic Fibrosis Conference (ECFS)
MENLO PARK, Calif. & DALLAS--(BUSINESS WIRE)--Jun 11, 2021--
Source: manchestertimes.com